Pembrolizumab: Injection concentrate for I.V. infusion 100 mg in 4 mL, Powder for injection 50 mg; Keytruda® Page last updated: 14 July 2017 Public Summary Document (PSD) March 2017 PBAC Meeting - (PDF 1.1MB) Public Summary Document (PSD) March 2017 PBAC Meeting - (Word 512KB)